Rhonda Naus
Medical · Ft Sam Houston, TXNPI 1437149309
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $32,506 of the $39,509 with a category attached, or 82.3%. Otsuka America Pharmaceutical, Inc. accounts for 94.2% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $19,183, more than ten times the $432 reported in 2021. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $182.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$37K
- Teva Pharmaceuticals USA, Inc.$441
- Neurocrine Biosciences, Inc.$344
- Validus Pharmaceuticals LLC$338
- Axsome Therapeutics, Inc.$250
- AbbVie$208
- plus $722 from 11 others
What the payments were for
- Speaking & faculty fees$32,50682%
- Travel & lodging$3,6129%
- Food & beverage$3,1818%
- Education$2101%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 117 | $37,206 |
| Teva Pharmaceuticals USA, Inc. | 5 | $441 |
| Neurocrine Biosciences, Inc. | 37 | $344 |
| Validus Pharmaceuticals LLC | 3 | $338 |
| Axsome Therapeutics, Inc. | 4 | $250 |
| AbbVie | 12 | $208 |
| Supernus Pharmaceuticals, Inc. | 14 | $182 |
| E.r. Squibb & Sons, L.L.C. | 4 | $148 |
| Johnson & Johnson | 5 | $80 |
| Alkermes, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $58 |
| Lundbeck LLC | 2 | $45 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $39 |
| Masimo Corporation | 1 | $36 |
| Corium, LLC | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$35,501
- Equetro$270
- Austedo XR$210
- Auvelity$103
How this compares
$39,509 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 15 | $2,222 |
| Quetiapine Fumarate | 81 | $1,218 |
| Fluoxetine Hcl | 51 | $620 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 17 | $496 |
| Trazodone Hcl | 39 | $392 |
| Duloxetine Hcl | 26 | $363 |
| Lamotrigine | 26 | $351 |
| Sertraline Hcl | 13 | $253 |
| Bupropion XlBupropion Hcl | 27 | $237 |
| Citalopram HbrCitalopram Hydrobromide | 20 | $153 |
| Escitalopram Oxalate | 26 | $147 |
| Gabapentin | 13 | $144 |
Paid to pharmacies, not to this prescriber.
Other medical in Ft Sam Houston
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Courtney AldridgeSan Antonio$89K
- Janine ShinnDallas$84K
- Radha BernanderKaty$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.